Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis—authors' reply

Sherry Yueh Hsia Chiu; Kuo Chin Chang; Tsung Hui Hu; Rong Nan Chien

doi:10.1111/apt.16339

Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis—authors' reply

Sherry Yueh Hsia Chiu
, Kuo Chin Chang
, Tsung Hui Hu
, Rong Nan Chien^*

^*Corresponding author for this work

Department of Health Care Management

Chang Gung University

Research output: Contribution to journal › Journal Letter › peer-review

Original language	English
Pages (from-to)	1042-1043
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	53
Issue number	9
DOIs	https://doi.org/10.1111/apt.16339
State	Published - 05 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/apt.16339

Cite this

@article{4d62a5dfd1844a7bad021899a1eb094d,

title = "Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis—authors' reply",

author = "Chiu, \{Sherry Yueh Hsia\} and Chang, \{Kuo Chin\} and Hu, \{Tsung Hui\} and Chien, \{Rong Nan\}",

year = "2021",

month = may,

doi = "10.1111/apt.16339",

language = "英语",

volume = "53",

pages = "1042--1043",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc",

number = "9",

}

Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis—authors' reply. / Chiu, Sherry Yueh Hsia; Chang, Kuo Chin; Hu, Tsung Hui et al.
In: Alimentary Pharmacology and Therapeutics, Vol. 53, No. 9, 05.2021, p. 1042-1043.

Research output: Contribution to journal › Journal Letter › peer-review

TY - JOUR

T1 - Letter

T2 - tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis—authors' reply

AU - Chiu, Sherry Yueh Hsia

AU - Chang, Kuo Chin

AU - Hu, Tsung Hui

AU - Chien, Rong Nan

PY - 2021/5

Y1 - 2021/5

UR - https://www.scopus.com/pages/publications/85104000252

U2 - 10.1111/apt.16339

DO - 10.1111/apt.16339

M3 - 快报

C2 - 33831240

AN - SCOPUS:85104000252

SN - 0269-2813

VL - 53

SP - 1042

EP - 1043

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 9

ER -

Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis—authors' reply

UN SDGs

Access to Document

Other files and links

Cite this